Memo Therapeutics AG Strengthens Management Team
February 05, 2024 07:00 ET
|
Memo Therapeutics AG
PRESS RELEASE Memo Therapeutics AG Strengthens Management Team Appoints Kristie B. Clemmer as VP Clinical Operations and Dr. Maartje Verschuur as VP CMC and Supply Chain Management ...
NodThera Announces Appointment of Dr. Thomas Jaecklin as Chief Medical Officer
February 05, 2024 07:00 ET
|
NodThera
Se NodThera Ltd (“NodThera” or the “Company”) NodThera Announces Appointment of Dr. Thomas Jaecklin as Chief Medical Officer BOSTON, MA, February 5, 2024 - NodThera, a leading clinical-stage...
Electric Metals (USA) Limited Announces Appointment of Chief Executive Officer
February 01, 2024 11:26 ET
|
Electric Metals (USA) Limited
TORONTO, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Electric Metals (USA) Limited (“EML” or the “Company”) (TSXV: EML) (OTCQB: EMUSF) is delighted to announce the appointment of Mr. Brian Savage to the...
Preqin welcomes new Head of Sales, APAC
January 31, 2024 19:30 ET
|
Preqin Ltd
LONDON, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Preqin, the global leader in alternative assets data, tools, and insights, announced the appointment of Gurkan Tasoren to Head of Sales, Asia-Pacific (APAC),...
Tome Biosciences Appoints Industry Veteran Daniel Curran, MD, to its Board of Directors
January 30, 2024 08:00 ET
|
Tome Biosciences
Tome Biosciences appoints Daniel Curran, MD, to its Board of Directors.
Preqin announces new Head of Benchmarks and Head of Research Insights
January 30, 2024 07:00 ET
|
Preqin Ltd
LONDON, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Preqin, the global leader in alternative assets data, tools, and insights, announced the appointment of key senior leaders to accelerate key products and...
Optimove Appoints Hila Shabtai Shemesh as VP of Finance
January 25, 2024 09:00 ET
|
Optimove
NEW YORK, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Optimove, the first Customer-Led Marketing Platform, announced today the appointment of Hila Shabtai Shemesh as the company's Vice President of Finance....
Transgene annonce la nomination de James Wentworth comme Directeur du Business Development
January 22, 2024 11:45 ET
|
Transgene S.A.
Strasbourg, France – Le 22 janvier 2023, 17 h 45 – Transgene (Euronext Paris : TNG), société de biotechnologie qui conçoit et développe des immunothérapies contre le cancer reposant sur des vecteurs...
Transgene Further Strengthens Management Team with Appointment of James Wentworth as Chief Business Officer
January 22, 2024 11:45 ET
|
Transgene S.A.
Strasbourg, France, January 22, 2024, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, is pleased...
NMD Pharma Appoints Morten Bull as SVP, General Counsel and Head of People & Business Services
January 22, 2024 07:00 ET
|
NMD Pharma
NMD Pharma Appoints Morten Bull as SVP, General Counsel and Head of People & Business Services Aarhus, Denmark, 22 January 2024 – NMD Pharma A/S, a clinical-stage biotech dedicated to...